Todos Medical Ltd. (TOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 27, 2026
Todos Medical Revenue
Todos Medical had revenue of $1.91M in the quarter ending September 30, 2022, with 89.50% growth. This brings the company's revenue in the last twelve months to $10.75M, down -7.84% year-over-year. In the year 2021, Todos Medical had annual revenue of $12.23M with 134.88% growth.
Revenue (ttm)
10.75M
Revenue Growth
-7.84%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.32K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 12.23M | 7.02M | 134.88% |
| Dec 31, 2020 | 5.21M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Response Genetics | 16.62M |
| T2 Biosystems | 7.68M |
| Medical Imaging | 7.52M |
| RushNet | 6.90M |
| HTG Molecular Diagnostics | 6.21M |
| Rosetta Genomics | 2.86M |
| Arrayit | 2.82M |
| Biocept | 1.36M |
Todos Medical News
- 2 years ago - Todos Medical Announces Insolvency Proceedings in Israel - GlobeNewsWire
- 2 years ago - Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic - GlobeNewsWire
- 2 years ago - Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients - GlobeNewsWire
- 3 years ago - Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics - GlobeNewsWire
- 3 years ago - Todos Medical Begins Trading on the OTC Pink Marketplace - GlobeNewsWire
- 3 years ago - Todos Medical Supports Long COVID Awareness Day - GlobeNewsWire
- 3 years ago - Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders - GlobeNewsWire
- 3 years ago - Todos Medical Provides Corporate Update - GlobeNewsWire